153 related articles for article (PubMed ID: 37545158)
1. Exploration of human pancreatic alpha-amylase inhibitors from Physalis peruviana for the treatment of type 2 diabetes.
Tiwari VP; Dubey A; Al-Shehri M; Tripathi IP
J Biomol Struct Dyn; 2024; 42(2):1031-1046. PubMed ID: 37545158
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and molecular dynamics studies of bioactive compounds contained in noni fruit (
Lolok N; Sumiwi SA; Muhtadi A; Susilawati Y; Hendriani R; Ramadhan DSF; Levita J; Sahidin I
J Biomol Struct Dyn; 2022 Sep; 40(15):7091-7098. PubMed ID: 33682637
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
[No Abstract] [Full Text] [Related]
4. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase.
Kikiowo B; Ahmad I; Alade AA; T Ijatuyi T; Iwaloye O; Patel HM
J Biomol Struct Dyn; 2023 Dec; 41(20):10388-10395. PubMed ID: 36524470
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations reveal the inhibitory mechanism of Withanolide A against α-glucosidase and α-amylase.
Oyewusi HA; Wu YS; Safi SZ; Wahab RA; Hatta MHM; Batumalaie K
J Biomol Struct Dyn; 2023; 41(13):6203-6218. PubMed ID: 35904027
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (
Ahmed S; Ali MC; Ruma RA; Mahmud S; Paul GK; Saleh MA; Alshahrani MM; Obaidullah AJ; Biswas SK; Rahman MM; Rahman MM; Islam MR
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889399
[No Abstract] [Full Text] [Related]
8. Assessments of Alpha-Amylase Inhibitory Potential of Tagetes Flavonoids through In Vitro, Molecular Docking, and Molecular Dynamics Simulation Studies.
Mohamed GA; Omar AM; El-Araby ME; Mass S; Ibrahim SRM
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373340
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of potential drug-like compounds from
Choudhury AA; V DR
J Biomol Struct Dyn; 2023 Dec; ():1-19. PubMed ID: 38116744
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antidiabetic activity of dietary phenolic compound chlorogenic acid in streptozotocin induced diabetic rats: Molecular docking, molecular dynamics, in silico toxicity, in vitro and in vivo studies.
Singh AK; Rana HK; Singh V; Chand Yadav T; Varadwaj P; Pandey AK
Comput Biol Med; 2021 Jul; 134():104462. PubMed ID: 34148008
[TBL] [Abstract][Full Text] [Related]
11. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
12. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
Riyaphan J; Pham DC; Leong MK; Weng CF
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
[TBL] [Abstract][Full Text] [Related]
13. Molecular modelling and in vitro studies of
Bhatnagar A; Saini R; Dagar P; Mishra A
J Biomol Struct Dyn; 2023 Jun; 41(9):3872-3883. PubMed ID: 35412420
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential human pancreatic α-amylase inhibitors from natural products by molecular docking, MM/GBSA calculations, MD simulations, and ADMET analysis.
Basnet S; Ghimire MP; Lamichhane TR; Adhikari R; Adhikari A
PLoS One; 2023; 18(3):e0275765. PubMed ID: 36928801
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
[TBL] [Abstract][Full Text] [Related]
16. Taxifolin prevents postprandial hyperglycemia by regulating the activity of α-amylase: Evidence from an in vivo and in silico studies.
Rehman K; Chohan TA; Waheed I; Gilani Z; Akash MSH
J Cell Biochem; 2019 Jan; 120(1):425-438. PubMed ID: 30191607
[TBL] [Abstract][Full Text] [Related]
17. In silico design of enzyme α-amylase and α-glucosidase inhibitors using molecular docking, molecular dynamic, conceptual DFT investigation and pharmacophore modelling.
Chenafa H; Mesli F; Daoud I; Achiri R; Ghalem S; Neghra A
J Biomol Struct Dyn; 2022 Sep; 40(14):6308-6329. PubMed ID: 33554773
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
[TBL] [Abstract][Full Text] [Related]
19. Identification of Dipeptidyl Peptidase-4 and α-Amylase Inhibitors from
Quek A; Kassim NK; Ismail A; Latif MAM; Shaari K; Tan DC; Lim PC
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374962
[TBL] [Abstract][Full Text] [Related]
20. Drug screening of α-amylase inhibitors as candidates for treating diabetes.
Alp M; Misturini A; Sastre G; Gálvez-Llompart M
J Cell Mol Med; 2023 Aug; 27(15):2249-2260. PubMed ID: 37403218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
